AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

10.97

+0.61 (5.89%)

At close: Aug 13, 2026, 4:00 PM EDT

10.96

-0.01 (-0.09%)

After-hours: Aug 13, 2026, 7:59 PM EDT

AbCellera Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,364	1,028	867	1,661	2,906	4,051
Market Cap Growth	163.60%	18.63%	-47.82%	-42.85%	-28.26%	-62.65%
Enterprise Value	2,959	631.63	301.7	971.25	2,096	3,364
Last Close Price	10.97	3.42	2.93	5.71	10.13	14.30

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	20.26	29.79
Forward PE	-	60.15	60.15	60.15	60.15	51.81
PEG Ratio	-	15.04	15.04	15.04	15.04	-
PS Ratio	50.83	13.68	30.05	43.67	5.99	10.80
PB Ratio	3.75	1.06	0.82	1.44	2.36	3.95
P/TBV Ratio	4.08	1.16	0.89	1.68	3.03	5.49
P/FCF Ratio	-	-	-	-	14.06	21.76
P/OCF Ratio	-	-	-	-	10.48	16.56

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	44.72	8.41	10.46	25.54	4.32	8.97
EV/EBITDA Ratio	-	-	-	-	8.40	15.18
EV/EBIT Ratio	-	-	-	-	9.68	16.46
EV/FCF Ratio	-	-	-	-	10.14	18.07

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.15	0.14	0.06	0.06	0.06	0.04
Debt / EBITDA Ratio	-	-	-	-	0.31	0.16
Debt / FCF Ratio	-	-	-	-	0.37	0.20
Net Debt / Equity Ratio	-0.46	-0.41	-0.53	-0.60	-0.66	-0.67
Net Debt / EBITDA Ratio	2.13	2.11	2.59	3.34	-3.24	-3.10
Net Debt / FCF Ratio	3.43	2.28	3.02	5.71	-3.92	-3.69
Asset Turnover	0.05	0.06	0.02	0.03	0.34	0.32
Quick Ratio	10.50	9.21	8.60	6.65	7.82	7.32
Current Ratio	12.77	11.32	9.81	7.33	8.67	7.70
Return on Equity (ROE)	-17.68%	-14.47%	-14.75%	-12.27%	14.03%	16.53%
Return on Assets (ROA)	-14.14%	-13.17%	-17.96%	-13.18%	10.04%	12.32%
Return on Invested Capital (ROIC)	-35.77%	-33.72%	-53.62%	-45.02%	37.64%	49.42%
Return on Capital Employed (ROCE)	-17.68%	-16.85%	-23.73%	-16.99%	16.52%	19.47%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-	-	-	-	4.94%	3.36%
FCF Yield	-	-	-	-	7.11%	4.60%
Buyback Yield / Dilution	-1.74%	-1.49%	-1.78%	8.15%	1.09%	-20.96%
Total Shareholder Return	-1.74%	-1.49%	-1.78%	8.15%	1.09%	-20.96%

SEC Filings: 10-K · 10-Q